1. Home
  2. EVAX vs CMND Comparison

EVAX vs CMND Comparison

Compare EVAX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • CMND
  • Stock Information
  • Founded
  • EVAX 2008
  • CMND 2017
  • Country
  • EVAX Denmark
  • CMND Canada
  • Employees
  • EVAX N/A
  • CMND N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • CMND Health Care
  • Exchange
  • EVAX Nasdaq
  • CMND Nasdaq
  • Market Cap
  • EVAX 8.7M
  • CMND 6.5M
  • IPO Year
  • EVAX 2021
  • CMND N/A
  • Fundamental
  • Price
  • EVAX $2.34
  • CMND $1.40
  • Analyst Decision
  • EVAX Strong Buy
  • CMND
  • Analyst Count
  • EVAX 3
  • CMND 0
  • Target Price
  • EVAX $33.33
  • CMND N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • CMND 113.9K
  • Earning Date
  • EVAX 03-26-2025
  • CMND 01-22-2025
  • Dividend Yield
  • EVAX N/A
  • CMND N/A
  • EPS Growth
  • EVAX N/A
  • CMND N/A
  • EPS
  • EVAX N/A
  • CMND N/A
  • Revenue
  • EVAX $3,295,000.00
  • CMND N/A
  • Revenue This Year
  • EVAX $4,845.21
  • CMND N/A
  • Revenue Next Year
  • EVAX $30.30
  • CMND N/A
  • P/E Ratio
  • EVAX N/A
  • CMND N/A
  • Revenue Growth
  • EVAX N/A
  • CMND N/A
  • 52 Week Low
  • EVAX $2.22
  • CMND $0.95
  • 52 Week High
  • EVAX $23.70
  • CMND $2.30
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 38.89
  • CMND 48.09
  • Support Level
  • EVAX $2.22
  • CMND $1.35
  • Resistance Level
  • EVAX $4.05
  • CMND $1.50
  • Average True Range (ATR)
  • EVAX 1.10
  • CMND 0.10
  • MACD
  • EVAX -0.02
  • CMND -0.01
  • Stochastic Oscillator
  • EVAX 2.11
  • CMND 30.56

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: